Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats

Pharmacology Biochemistry and Behavior

Volumn 107, Issue , 2013, Pages 20-23

  Koike, Hiroyuki ^a   Iijima, Michihiko ^a   Chaki, Shigeyuki ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Corticosterone; Forced swim test; Ketamine; LY341495

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; CORTICOSTERONE; KETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRIC POTENTIAL; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT RESISTANT DEPRESSION;

AMINO ACIDS; ANIMALS; CORTICOSTERONE; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; IMMOBILITY RESPONSE, TONIC; INJECTIONS, SUBCUTANEOUS; KETAMINE; MALE; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; XANTHENES;

RATTUS;

EID: 84877012931     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.03.017     Document Type: Article

References (36)

1. M. aan het Rot, K.A. Collins, J.W. Murrough, A.M. Perez, D.L. Reich, and D.S. Charney Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 2010 139 145
2. Y. Ago, S. Arikawa, M. Yata, K. Yano, M. Abe, and K. Takuma Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression Neuropharmacology 55 2008 1355 1363
3. D.P. Auer, B. Pütz, E. Kraft, B. Lipinski, J. Schill, and F. Holsboer Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study Biol Psychiatry 47 2000 305 313
4. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, and P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
5. S. Chaki, Y. Ago, A. Palucha-Paniewiera, F. Matrisciano, and A. Pilc mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants Neuropharmacology 66 2013 40 52
6. P.V. Choudary, M. Molnar, S.J. Evans, H. Tomita, J.Z. Li, and M.P. Vawter Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression Proc Natl Acad Sci U S A 102 2005 15653 15658
7. N. DiazGranados, L.A. Ibrahim, N.E. Brutsche, R. Ameli, I.D. Henter, and D.A. Luckenbaugh Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder J Clin Psychiatry 71 2010 1605 1611
8. Y. Dwivedi, H.S. Rizavi, and G.N. Pandey Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone Neuroscience 139 2006 1017 1029
9. 2/3 blockade Int J Neuropsychopharmacol 15 2012 429 434
10. S.L. Gourley, and J.R. Taylor Recapitulation and reversal of a persistent depression-like syndrome in rodents Curr Protoc Neurosci 2009 [Chapter 9: Unit 9.32]
11. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol Psychiatry 62 2007 1310 1316
12. K.R. Howell, A. Kutiyanawalla, and A. Pillai Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex PLoS One 6 2011 e20198
13. M. Iijima, A. Ito, S. Kurosu, and S. Chaki Pharmacological characterization of repeated corticosterone injection-induced depression model in rats Brain Res 1359 2010 75 80
14. J.P. Jacobsen, and A. Mørk Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat Brain Res 1110 2006 221 225
15. S.A. Johnson, N.M. Fournier, and L.E. Kalynchuk Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor Behav Brain Res 168 2006 280 288
16. M.F. Juruena, C.M. Pariante, A.S. Papadopoulos, L. Poon, S. Lightman, and A.J. Cleare Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance Br J Psychiatry 194 2009 342 349
17. A.E. Kingston, P.L. Ornstein, R.A. Wright, B.G. Johnson, N.G. Mayne, and J.P. Burnett LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors Neuropharmacology 37 1998 1 12
18. H. Koike, M. Iijima, and S. Chaki Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression Behav Brain Res 224 2011 107 111
19. H. Koike, M. Iijima, and S. Chaki Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists Neuropharmacology 61 2011 1419 1423
20. H. Koike, K. Fukumoto, M. Iijima, and S. Chaki Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression Behav Brain Res 238 2013 48 52
21. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, and M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
22. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, and H. Son Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol Psychiatry 69 2011 754 761
23. R.J. Liu, and G.K. Aghajanian Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy Proc Natl Acad Sci U S A 105 2008 359 364
24. R.J. Liu, F.S. Lee, X.Y. Li, F. Bambico, R.S. Duman, and G.K. Aghajanian Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex Biol Psychiatry 71 2012 996 1005
25. H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C.R. Ashby Jr., and R. Kawahara Correlation between plasma levels of glutamate, alanine and serine with severity of depression Prog Neuropsychopharmacol Biol Psychiatry 30 2006 1155 1158
26. J.C. Morales-Medina, F. Sanchez, G. Flores, Y. Dumont, and R. Quirion Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat J Chem Neuroanat 38 2009 266 272
27. B.E. Murphy, V. Dhar, A.M. Ghadirian, G. Chouinard, and R. Keller Response to steroid suppression in major depression resistant to antidepressant therapy J Clin Psychopharmacol 11 1991 121 126
28. S. Nudmamud-Thanoi, and G.P. Reynolds The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders Neurosci Lett 372 2004 173 177
29. B. Pfleiderer, N. Michael, A. Erfurth, P. Ohrmann, U. Hohmann, and M. Wolgast Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients Psychiatry Res 122 2003 185 192
30. R.B. Price, M.K. Nock, D.S. Charney, and S.J. Mathew Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression Biol Psychiatry 66 2009 522 526
31. G. Sanacora, R. Gueorguieva, C.N. Epperson, Y.T. Wu, M. Appel, and D.L. Rothman Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression Arch Gen Psychiatry 61 2004 705 713
32. E.Y. Sterner, and L.E. Kalynchuk Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression Prog Neuropsychopharmacol Biol Psychiatry 34 2010 777 790
33. J.M. Witkin, J. Monn, T. Brittion, P. Ornstein, X. Li, and B.G. Johnson Further evidence for a metabotropic glutamate group II antagonist mechanism for the induction of antidepressant-like effects in rodents Neuropsychopharmacology 2006 S166
34. T. Yoshimizu, T. Shimazaki, A. Ito, and S. Chaki An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats Psychopharmacology (Berl) 186 2006 587 593
35. C.A. Zarate Jr., J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
36. C.A. Zarate Jr., N.E. Brutsche, L. Ibrahim, J. Franco-Chaves, N. Diazgranados, and A. Cravchik Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol Psychiatry 71 2012 939 946